FDA Inspection
Everest Organics LimitedEverest Organics Limited – FDA Inspection, Mar 3, 2017
Record Details
This FDA Inspection record concerns Everest Organics Limited, with an inspection on March 3, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 095bfc45-c793-4f14-8a70-284eb19dea67
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1006039
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Everest Organics Limited
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 1, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Everest Organics Limited
- FDA Inspection 1236234 - 2024-03-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.